Biochemical composition for treating intractable skin disease fungi

A technology of biochemistry and composition, applied in skin diseases, drug combinations, antifungal agents, etc., can solve problems affecting patients' work and life

Inactive Publication Date: 2022-01-04
安徽云讯生物技术有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Intractable anal itching, intractable groin itching, and intractable beriberi are the most common intractable skin pruritus. For this reason, domestic drug manufacturers have developed a variety of ointments on the market. Pruritus, obstinate beriberi, the most common intractable skin pruritus, is effective for the first time with an ointment. After stopping using it, after a period of time, it recurs again. When the patient uses this ointment again, no matter how much it is used For a long time, found invalid
[0003] The speed at which domestic drug manufacturers develop ointments is not as fast as the speed at which the most common intractable skin pruritus, such as intractable anal itching, intractable groin itching, and intractable beriberi, develop resistance, causing many patients to suffer from this intractable skin disease. Scrapie, with a course of several years to more than ten years, has seriously affected the patient's work and life
There is currently no ointment for long-term treatment of pruritus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biochemical composition for treating intractable skin disease fungi
  • Biochemical composition for treating intractable skin disease fungi
  • Biochemical composition for treating intractable skin disease fungi

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A biochemical composition for treating intractable dermatosis fungus, comprising the following active ingredients: 0.4 mg / g polysulfonate mucopolysaccharide, 0.4 mg / g ketoconazole, and 0.05 mg / g clobetasol propionate.

[0020] The following weight raw materials are adopted in every 10g composition prepared: ketoconazole 4mg, clobetasol propionate 0.5mg, mucopolysaccharide polysulfonate 4mg, neomycin sulfate 30,000 units, stearyl alcohol 1g, white petrolatum 500mg, Liquid paraffin 200mg, glycerin 200mg, leveling agent O 100mg, isopropyl myristate 100mg, ethylparaben 15mg, dimethyl sulfoxide 150mg, propylene glycol 100mg, essence 2mg, and the balance is purified water.

[0021] A preparation method of a biochemical composition for treating refractory dermatosis fungi, comprising the steps of:

[0022] (1) Prepare the water phase: put the water phase materials glycerin, leveling agent O, neomycin sulfate, isopropyl myristate, ethylparaben and purified water into the water ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a biochemical composition for treating intractable skin disease fungi, and the ointment comprises the following effective components: 0.4 mg/g of mucopolysaccharide polysulfate, 0.4 mg/g of ketoconazole and 0.05 mg/g of clobetasol propionate. The ointment provided by the invention has no side effect, and can quickly inhibit and eliminate pathogenic bacteria in an active period and thoroughly kill pathogenic bacteria in a dormant period. The ointment is applied to an affected part twice a day and is continuously used for 8 days, so that intractable pruritus ani, intractable groin pruritus and intractable beriberi are prevented from relapse within 360 days.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to a biochemical composition for treating intractable skin disease fungi. Background technique [0002] Intractable anal itching, intractable groin itching, and intractable beriberi are the most common intractable skin pruritus. For this reason, domestic drug manufacturers have developed a variety of ointments on the market. Pruritus, obstinate beriberi, the most common intractable skin pruritus, is effective for the first time with an ointment. After stopping using it, after a period of time, it recurs again. When the patient uses this ointment again, no matter how much it is used For a long time, it was found to be invalid. [0003] The speed at which domestic drug manufacturers develop ointments is not as fast as the speed at which the most common intractable skin pruritus, such as intractable anal itching, intractable groin itching, and intractable beriberi, develop resistance...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/715A61K31/496A61K31/573A61K31/7036A61K9/06A61P17/00A61P31/10A61P17/04
CPCA61K31/715A61K31/496A61K31/573A61K31/7036A61K9/06A61K9/0014A61P17/00A61P31/10A61P17/04A61K2300/00
Inventor 任云超
Owner 安徽云讯生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products